Phio Pharmaceuticals Corp. (PHIO)
1.06
-0.03
(-2.75%)
USD |
NASDAQ |
Sep 01, 12:01
Phio Pharmaceuticals Net Income (TTM) : -12.90M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.90M |
| March 31, 2026 | -10.93M |
| December 31, 2025 | -8.698M |
| September 30, 2025 | -7.953M |
| June 30, 2025 | -7.085M |
| March 31, 2025 | -6.765M |
| December 31, 2024 | -7.15M |
| September 30, 2024 | -7.419M |
| June 30, 2024 | -8.675M |
| March 31, 2024 | -9.378M |
| December 31, 2023 | -10.83M |
| September 30, 2023 | -11.66M |
| June 30, 2023 | -12.46M |
| March 31, 2023 | -12.44M |
| December 31, 2022 | -11.48M |
| September 30, 2022 | -12.20M |
| June 30, 2022 | -12.37M |
| March 31, 2022 | -12.52M |
| December 31, 2021 | -13.29M |
| September 30, 2021 | -12.30M |
| June 30, 2021 | -10.86M |
| March 31, 2021 | -9.85M |
| December 31, 2020 | -8.794M |
| September 30, 2020 | -8.992M |
| June 30, 2020 | -8.777M |
| Date | Value |
|---|---|
| March 31, 2020 | -9.14M |
| December 31, 2019 | -8.908M |
| September 30, 2019 | -7.975M |
| June 30, 2019 | -7.374M |
| March 31, 2019 | -7.24M |
| December 31, 2018 | -7.36M |
| September 30, 2018 | -7.635M |
| June 30, 2018 | -8.618M |
| March 31, 2018 | -9.231M |
| December 31, 2017 | -12.45M |
| September 30, 2017 | -12.79M |
| June 30, 2017 | -12.52M |
| March 31, 2017 | -12.22M |
| December 31, 2016 | -8.994M |
| September 30, 2016 | -9.271M |
| June 30, 2016 | -9.555M |
| March 31, 2016 | -9.509M |
| December 31, 2015 | -10.22M |
| September 30, 2015 | -9.911M |
| June 30, 2015 | -9.621M |
| March 31, 2015 | -9.461M |
| December 31, 2014 | -8.80M |
| September 30, 2014 | -9.004M |
| June 30, 2014 | -8.857M |
| March 31, 2014 | -8.812M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Imunon, Inc. | -14.72M |
| Agenus, Inc. | 91.94M |
| Amgen, Inc. | 8.743B |
| Anika Therapeutics, Inc. | -3.121M |
| BioCryst Pharmaceuticals, Inc. | -384.67M |